The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males (Q92207864)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males |
clinical trial |
Statements
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Rising Dose Study of AR882, a Potent Uricosuric Agent, in Healthy Adult Male Volunteers (English)
0 references
22 January 2019
0 references
31 July 2019
0 references
64
0 references
18 year
0 references
55 year
0 references